Group 1 - The Ministry of Industry and Information Technology, along with six other departments, issued a document to promote the innovation and development of the brain-computer interface (BCI) industry, aiming for breakthroughs in key technologies by 2027 [1] - The BCI technology is expected to achieve international advanced levels in electrode, chip, and complete product performance, with applications expanding in industrial manufacturing, healthcare, and consumer life [1] - The global market for BCI medical applications is projected to reach $40 billion by 2030 and $145 billion by 2040 according to McKinsey [1] Group 2 - Local governments are actively supporting the BCI industry with various policies, such as Beijing's action plan targeting commercialization in healthcare, wellness, industrial, and educational fields by 2030 [2] - Companies like Xilinmen and Sanbo Brain Science are entering the BCI field, with Xilinmen launching a smart mattress that integrates brain monitoring technology [2] - Other listed companies are also making strides in material research and AI healthcare, contributing to the BCI industry's supply chain [3] Group 3 - Experts indicate that non-invasive BCI commercialization is progressing rapidly in education and entertainment, while invasive technologies excel in precise control and neuro-rehabilitation [3] - The BCI industry in China benefits from policy support, technological foundation, market space, and application demand, but faces challenges such as technical bottlenecks and ethical concerns [3] - Recommendations include accelerating collaboration on software, hardware, algorithms, and ethics, as well as improving data privacy protection and encouraging leading companies to build public pilot platforms [3]